SCOPUS 정보 검색 플랫폼

Journal of Cancer Research and Clinical Oncology

Volumn 125, Issue 8-9, 1999, Pages 520-524

Therapy of metastatic breast cancer with humanized antibodies against the HER2 receptor protein

(6) Schaller, G a Bangemann, N a Becker, Ch a Buhler H a Opri, F a Weitzel, H K a

a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN (Germany)

Author keywords

Breast cancer; gp185 Immuno therapy; HER2; Humanized antibodies

Indexed keywords

ANTHRACYCLINE; CHIMERIC ANTIBODY; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR DERIVATIVE; EPIRUBICIN; HER2 RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; ONCOPROTEIN; PACLITAXEL; TRASTUZUMAB; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DESIGN; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; ESCHERICHIA COLI; GENETIC ENGINEERING; HAMSTER; HEART DISEASE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MOLECULAR MODEL; MOUSE; NONHUMAN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CLINICAL TRIALS, PHASE III; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RECEPTOR, ERBB-2; TREATMENT OUTCOME; UP-REGULATION;

EID: 0032841436 PISSN: 01715216 EISSN: None Source Type: Journal
DOI: 10.1007/s004320050311 Document Type: Article

Times cited : (23)

References (13)

1
- 0029991439
- HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer
- HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J Clin Oncol 14:737-744
- (1996) J Clin Oncol , vol.14 , pp. 737-744
- Baselga, J.¹ Tripathy, D.² Mendelsohn, J.³ Baughman, S.⁴ Benz, C.C.⁵ Dantis, L.⁶ Sklarin, N.T.⁷ Seidman, A.D.⁸ Hudis, C.A.⁹ Moore, J.¹⁰ Rosen, P.P.¹¹ Twaddell, T.¹² Henderson, I.C.¹³ Norton, L.¹⁴

2
- 0027074588
- Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu
- Benz CC, Scott GK, Sarup JC, Johnson RM, Tripathy D, Coronado E, Shepard HM, Osborne CK (1993) Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu. Breast Cancer Res Treat 24:85-95
- (1993) Breast Cancer Res Treat , vol.24 , pp. 85-95
- Benz, C.C.¹ Scott, G.K.² Sarup, J.C.³ Johnson, R.M.⁴ Tripathy, D.⁵ Coronado, E.⁶ Shepard, H.M.⁷ Osborne, C.K.⁸

3
- 0001240878
- 20 Year update of the naples gun trial of adjuvant breast cancer therapy: Evidence of interaction between c-erb-B2 expression and tamoxifen efficacy
- Blanco AR, De Laurentils M, Carlomagno C, Lauria R, Petrella G, Panico L, Pettinato G, Perrone F, Gallo C, Marinelli A, De Placido S (1998) 20 year update of the naples gun trial of adjuvant breast cancer therapy: evidence of interaction between c-erb-B2 expression and tamoxifen efficacy. Proc Am Assoc Cancer Res Annu Meet 17:97a
- (1998) Proc Am Assoc Cancer Res Annu Meet , vol.17
- Blanco, A.R.¹ De Laurentils, M.² Carlomagno, C.³ Lauria, R.⁴ Petrella, G.⁵ Panico, L.⁶ Pettinato, G.⁷ Perrone, F.⁸ Gallo, C.⁹ Marinelli, A.¹⁰ De Placido, S.¹¹

4
- 0028360192
- ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer
- Borg A, Baldetorp B, Ferno M, Killander D, Olsson H, Ryden S, Sigurdsson H (1994) ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer (letter). Cancer 81:137-144
- (1994) Cancer , vol.81 , pp. 137-144
- Borg, A.¹ Baldetorp, B.² Ferno, M.³ Killander, D.⁴ Olsson, H.⁵ Ryden, S.⁶ Sigurdsson, H.⁷

5
- 0026610881
- Humanization of an anti-p185 HER2 antibody for human cancer therapy
- Carter P, Presta L, Gorman CM, Ridgway JB, Henner D, Wong WL, Rowland AM, Kotts C, Carver ME, Shepard HM (1992) Humanization of an anti-p185 HER2 antibody for human cancer therapy. Proc Natl Acad Sci USA 89:4285-4289
- (1992) Proc Natl Acad Sci USA , vol.89 , pp. 4285-4289
- Carter, P.¹ Presta, L.² Gorman, C.M.³ Ridgway, J.B.⁴ Henner, D.⁵ Wong, W.L.⁶ Rowland, A.M.⁷ Kotts, C.⁸ Carver, M.E.⁹ Shepard, H.M.¹⁰

6
- 0003237802
- HER-2/neu peptide vaccines elicit T cell immunity to the HER-2/neu protein in patients with breast and ovarian cancer
- Disis ML, Grabstein KH, Sleath PR, Cheever MA (1998) HER-2/neu peptide vaccines elicit T cell immunity to the HER-2/neu protein in patients with breast and ovarian cancer. Am Assoc Cancer Res Annu Meet 17:97a
- (1998) Am Assoc Cancer Res Annu Meet , vol.17
- Disis, M.L.¹ Grabstein, K.H.² Sleath, P.R.³ Cheever, M.A.⁴

7
- 0026718827
- ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridisation
- Kallioniemi OP, Kallioniemi A, Kurisu W, Thor A, Chen LC, Smith HS, Waldman FM, Pinkel D, Gray JW (1992) ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridisation. Proc Natl Acad Sci USA 89:5321-5325
- (1992) Proc Natl Acad Sci USA , vol.89 , pp. 5321-5325
- Kallioniemi, O.P.¹ Kallioniemi, A.² Kurisu, W.³ Thor, A.⁴ Chen, L.C.⁵ Smith, H.S.⁶ Waldman, F.M.⁷ Pinkel, D.⁸ Gray, J.W.⁹

8
- 0026843158
- Mechanisms of p185HER2 expression in human non-small cell lung cancer cell lines
- Kern JA, Robinson RA, Gazdar A, Torney L, Weiner DB (1992) Mechanisms of p185HER2 expression in human non-small cell lung cancer cell lines. Am J Respir Cell Mol Biol 6:359-363
- (1992) Am J Respir Cell Mol Biol , vol.6 , pp. 359-363
- Kern, J.A.¹ Robinson, R.A.² Gazdar, A.³ Torney, L.⁴ Weiner, D.B.⁵

9
- 0030965101
- Cleaning up on β-catenin
- Nakamura Y (1997) Cleaning up on β-catenin. Nat Med 3:499-500
- (1997) Nat Med , vol.3 , pp. 499-500
- Nakamura, Y.¹

10
- 0020117514
- Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas
- Pady LC, Shih C, Crowing D, Finkelstein R, Weinberg RA (1982) Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas. Cell 28:865-871
- (1982) Cell , vol.28 , pp. 865-871
- Pady, L.C.¹ Shih, C.² Crowing, D.³ Finkelstein, R.⁴ Weinberg, R.A.⁵

11
- 0025804023
- Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic
- Shepard HM, Lewis GD, Sarup JC, Fendly BM, Maneval D, Mordenti J, Figari I, Kotts CE, Palladino MA Jr, Ullrich A, et al (1991) Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic. J Clin Immunol 11:117-127
- (1991) J Clin Immunol , vol.11 , pp. 117-127
- Shepard, H.M.¹ Lewis, G.D.² Sarup, J.C.³ Fendly, B.M.⁴ Maneval, D.⁵ Mordenti, J.⁶ Figari, I.⁷ Kotts, C.E.⁸ Palladino M.A., Jr.⁹ Ullrich, A.¹⁰

12
- 37049183697
- Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
- Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182
- (1987) Science , vol.235 , pp. 177-182
- Slamon, D.J.¹ Clark, G.M.² Wong, S.G.³ Levin, W.J.⁴ Ullrich, A.⁵ McGuire, W.L.⁶

13
- 0024337144
- Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
- Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, et al (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712
- (1989) Science , vol.244 , pp. 707-712
- Slamon, D.J.¹ Godolphin, W.² Jones, L.A.³ Holt, J.A.⁴ Wong, S.G.⁵ Keith, D.E.⁶ Levin, W.J.⁷ Stuart, S.G.⁸ Udove, J.⁹ Ullrich, A.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.